Mayo Clinic trial signals potential for AI-guided heart dise

Mayo Clinic trial signals potential for AI-guided heart disease detection


Photo by FG Trade/Getty Images
The Mayo Clinic released results of a trial this week that suggests potential for artificial intelligence to assist with early diagnosis of some types of heart disease.  
The study, published in
Nature Medicine on Thursday, found that an AI-enabled electrocardiogram increased the diagnosis of low ejection fraction.  
"The AI-enabled EKG facilitated the diagnosis of patients with low ejection fraction in a real-world setting by identifying people who previously would have slipped through the cracks," said Dr. Peter Noseworthy, a Mayo Clinic cardiac electrophysiologist who was the senior author on the study, in a press release.    

Related Keywords

Minnesota , United States , Peter Noseworthy , Xiaoxi Yao , Kat Jercich , Drug Administration , Mayo Clinic , Nature Medicine , Guided Screening , Low Ejection Fraction , மினசோட்டா , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் மூக்குத்தி , மயோ சிகிச்சையகம் , இயற்கை மருந்து , குறைந்த வெளியேற்றம் பின்னம் ,

© 2025 Vimarsana